Status:
COMPLETED
Pulmonary and Extrapulmonary Impairments in Patients With Post COVID-19
Lead Sponsor:
Gazi University
Conditions:
COVID-19
Eligibility:
All Genders
18-75 years
Brief Summary
Pulmonary involvement and fibrosis could be seen in patients after COVID-19. Especially diffusion capacity, pulmonary function, exercise capacity and muscle strength have decreased in patients with CO...
Detailed Description
Patients who had diagnosed with COVID-19 and participants who do not have any diagnosed disease will be evaluated in this study. Twenty-five patients with post COVID-19 and 25 age- and sex-matched hea...
Eligibility Criteria
Inclusion
- Patients;
- aged between 18-75 years
- diagnosed with COVID-19 before
- patients whose COVID-19 Polymerase Chain Reaction test turned negative or be negative already
- patients who are willing to participate in this study.
- Healthy controls;
- aged between 18-75 years
- patients who are willing to participate in this study.
Exclusion
- Patients;
- body mass index \>35 kg/m2
- cancer, renal or hepatic diseases
- aortic stenosis, complex arrhythmia, aortic aneurysm
- serious neurological, neuromuscular, orthopedic, other systemic diseases or. other diseases affecting physical functions
- uncontrolled hypertension and/or diabetes mellitus, heart failure and cardiovascular disease
- acute pulmonary exacerbation, acute upper or lower respiratory tract infection
- cognitive impairment that causes difficulty in understanding and following exercise test instructions
- bulla formation in the lung
- participated in a planned exercise program in the last three months
- contraindication for exercise testing and/or exercise training according to the American College of Sports Medicine
- Healthy controls;
- history of coronavirus disease
- history of smoke exposure below 10 packs\*years
- have any diagnosed chronic or systemic diseases
- have psychiatric disorder
- body mass index \>35 kg/m2
- cognitive impairment that causes difficulty in understanding and following exercise test instructions
- acute pulmonary exacerbation, acute upper or lower respiratory tract infection
Key Trial Info
Start Date :
May 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 20 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05381727
Start Date
May 15 2022
End Date
December 20 2024
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gazi University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Clinic
Ankara, Turkey (Türkiye), 06560